White. ‘Our mission is to de-centralize molecular diagnostics.’.. Adnavance Technologies to present its DNA direct detection technology in the AdvaMed 2009 Adnavance Technologies Inc., a programmer of direct detection molecular diagnostic assessments for medical applications, announced today that Randy Light, Ph.D. Ceo, will present initial data supporting direct recognition of DNA targets in human clinical samples during company presentations at the following conferences: AdvaMed 2009 on Tuesday, October 13, 2009 at 10:00 a.m. Eastern Time at the Walter E. Washington Convention Middle in Washington, D.C. BIOCOM’s 4th Annual Investor Conference on Monday, 26 October, 2009 at 10:00 a.m.Establishing a substantive body of cancers care research centered on the experiences of individuals and carers, throughout all phases of their disease. Exploring a range of methods to capture the views of individuals, carers and the public about cancer care in Scotland. Involving individuals and carers in directing the experience of the Centre. These details will be of use to everyone with an intention in malignancy in Scotland. today announced that it is proposing to issue $150 million in senior unsecured notes due 2021 in an exclusive offering that’s exempt from the sign up requirements of the Securities Act of 1933, as amended . The ongoing firm intends to use the net arises from the offering for general corporate purposes, which may consist of acquisitions.